The time to benefit from intensive hypertensive control is now
J Am Geriatr Soc
.
2022 May;70(5):1355-1357.
doi: 10.1111/jgs.17729.
Epub 2022 Mar 22.
Author
Mark A Supiano
1
2
Affiliations
1
Division of Geriatrics, Spencer Fox Eccles School of Medicine, Salt Lake City, Utah, USA.
2
University of Utah Center on Aging, Salt Lake City, Utah, USA.
PMID:
35315514
DOI:
10.1111/jgs.17729
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Antihypertensive Agents / pharmacology
Antihypertensive Agents / therapeutic use
Blood Pressure
Humans
Hypertension* / drug therapy
Substances
Antihypertensive Agents
Grants and funding
R01 AG055606/AG/NIA NIH HHS/United States
R01 AG074592/AG/NIA NIH HHS/United States
R33 AG068483/AG/NIA NIH HHS/United States
U19 AG065188/AG/NIA NIH HHS/United States